You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
HusdonAlpha Health Alliance is a nonprofit formed in 2019 to provide genomic health screening services for organizations including health systems and employers.
The company is planning to fund projects for SARS-CoV-2 testing, early disease detection, disease prognostics, and public health genomics projects.
The investment bank said it believes Twist's high growth is "sustainable" and that synthetic biology is the most exciting market in the life sciences sector.
Last week, GenomeWeb's readers were most interested in Invitae's plan to acquire Genosity for $200 million.
The partners hope to improve variant interpretation by linking Limbus Medical's clinical decision support system with Genomenon's literature search tool.
Lucira Health's at-home molecular test received Emergency Use Authorization in November for prescription use.
DiaSorin said that the transaction is expected to be immediately accretive to its earnings per share and result in cost synergies of about $55 million within three years.
Sequence data on more than 800 farm or wastewater Enterobacteriaceae isolates suggested pangenome dynamics may be influenced by geography and environmental niches.
With gut microbiome data for individuals sampled four years apart, researchers saw stable and unstable gut microbial species, including those linked to host phenotypes.
The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.
According to the Associated Press, a Swiss program aims to shepherd long-term science projects and diplomacy.
CNN reports that two new studies suggest the B.1.1.7 SARS-CoV-2 variant may be more transmissible, but may not lead to more severe disease.
In PNAS this week: analysis of pathway affecting acute kidney injury, parental-specific allelic expression in horse placenta, and more.